Animalcare Group PLC
LSE:ANCR
Animalcare Group PLC
LSE:ANCR
Price:
245
GBX
-0.41%
Market Closed
Market Cap:
£169.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Animalcare Group PLC
LSE:ANCR
|
UK |
|
C
|
Chularat Hospital PCL
SET:CHG
|
TH |
|
H
|
Hubei Guochuang Hi-tech Material Co Ltd
SZSE:002377
|
CN |
|
Pandox AB
STO:PNDX B
|
SE |
|
F
|
Ferrotec An Hui Technology Development Co Ltd
SZSE:301297
|
CN |
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
CN |
|
Sieyuan Electric Co Ltd
SZSE:002028
|
CN |
|
Jayride Group Ltd
ASX:JAY
|
AU |
|
C
|
Charan Insurance PCL
SET:CHARAN
|
TH |
|
TPI Triunfo Participacoes e Investimentos SA
BOVESPA:TPIS3
|
BR |
|
Balmer Lawrie and Company Ltd
NSE:BALMLAWRIE
|
IN |
Relative Value
The Relative Value of one
ANCR
stock under the Base Case scenario is
hidden
GBX.
Compared to the current market price of 245 GBX,
Animalcare Group PLC
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ANCR Relative Value
HIDDEN
Multiples Across Competitors
ANCR Competitors Multiples
Animalcare Group PLC Competitors
Animalcare Group PLC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
|
Animalcare Group PLC
LSE:ANCR
|
169.7m GBP | 2.1 | 56.7 | 13.4 | 35.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
853.2B USD | 13.1 | 41.3 | 27.9 | 29.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.5B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 4 | 18.9 | 11.2 | 12.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
213.1B GBP | 4.9 | 28.1 | 15.6 | 22 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
288B USD | 4.4 | 15.8 | 9.8 | 11.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
222.8B CHF | 5.2 | 20.8 | 12.9 | 16.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.3 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.3B USD | 2.4 | 19.7 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.5B USD | 2.4 | 16.4 | 7 | 8.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
